Found: 11
Select item for more details and to access through your institution.
Norcantharidin enhances TIMP-2 anti-vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP-2 and MT1-MMP.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 2, p. 627, doi. 10.3892/ijo.2014.2753
- By:
- Publication type:
- Article
CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 5, p. 6399, doi. 10.3390/ijms13056399
- By:
- Publication type:
- Article
Vibration analysis of triplex pump installed on the fracturing truck based on ADAMS.
- Published in:
- Journal of Mechanical & Electrical Engineering, 2014, v. 31, n. 11, p. 1361, doi. 10.3969/j.issn.1001-4551.2014.11.009
- By:
- Publication type:
- Article
Discontinuous Galerkin Immersed Finite Volume Element Method for Anisotropic Flow Models in Porous Medium.
- Published in:
- Abstract & Applied Analysis, 2014, p. 1, doi. 10.1155/2014/520404
- By:
- Publication type:
- Article
Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin <i>via</i> Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096982
- By:
- Publication type:
- Article
Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.
- Published in:
- Cancer Cell International, 2017, v. 17, p. 1, doi. 10.1186/s12935-017-0388-8
- By:
- Publication type:
- Article
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1521-5
- By:
- Publication type:
- Article
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro...
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 527, doi. 10.1186/s12885-015-1521-5
- By:
- Publication type:
- Article
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/ Ln-5γ2 signaling pathway.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-193
- By:
- Publication type:
- Article
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-193
- By:
- Publication type:
- Article
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
- Published in:
- 2014
- By:
- Publication type:
- journal article